The incremental value of brachial flow-mediated dilation measurements in risk stratification for incident cardiovascular events: A systematic review

Annals of Medicine

Volumn 44, Issue 4, 2012, Pages 305-312

  Peters, Sanne A E ^a   Den Ruijter, Hester M ^a   Bots, Michiel L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atherosclerosis; Flow mediated dilation; Imaging; Prevention; Risk stratification

Indexed keywords

ARTERY DILATATION; ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLASSIFICATION; CLINICAL PRACTICE; FLOW MEDIATED DILATION; HUMAN; MEDLINE; MODEL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK; RISK ASSESSMENT; RISK FACTORS; VASODILATION;

EID: 84860141191     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2011.579149     Document Type: Review

References (40)

1. World Health Organization. The World Health Report 2008. Available at: URL: http://www.who.int/whr/en/(accessed 7 June 2009).
2. Cavanaugh-Hussey MW, Berry JD, Lloyd-Jones DM. Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool. Prev Med. 2008;47:619-23.
3. Schlendorf KH, Nasir K, Blumenthal RS. Limitations of the Framingham risk score are now much clearer. Prev Med. 2009;48:115-6.
4. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-5.
5. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36. (Pubitemid 20209469)
6. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149-60. (Pubitemid 37188333)
7. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent fl ow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257-65. (Pubitemid 34084631)
8. Inaba Y, Chen JA, Bergmann SR. Prediction of future cardiovascular outcomes by fl ow-mediated vasodilatation of brachial artery: a meta-analysis. Int J Cardiovasc Imaging. 2010;26:631-40.
9. Lau KK, Chan YH, Yiu KH, Tam S, Li SW, Lau CP, et al. Incremental predictive value of vascular assessments combined with the Framingham Risk Score for prediction of coronary events in subjects of low-intermediate risk. Postgrad Med J. 2008;84:153-7. (Pubitemid 351498012)
10. Suzuki T, Hirata K, Elkind MS, Jin Z, Rundek T, Miyake Y, et al. Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS). Am Heart J. 2008;156:405-10.
11. Corrado E, Rizzo M, Coppola G, Muratori I, Carella M, Novo S. Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study. Coron Artery Dis. 2008;19:139-44. (Pubitemid 351555966)
12. Shechter M, Issachar A, Marai I, Koren-Morag N, Freinark D, Shahar Y, et al. Long-term association of brachial artery fl ow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol. 2009;134:52-8.
13. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial fl ow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation. 2007;115:2390-7. (Pubitemid 46717961)
14. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, et al. Predictive value of brachial fl ow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation. 2009;120:502-9.
15. Aboyans V, Guilloux J, Lacroix P, Yildiz C, Postil A, Laskar M. Common carotid intima-media thickness measurement is not a pertinent predictor for secondary cardiovascular events after coronary bypass surgery. A prospective study. Eur J Cardiothorac Surg. 2005;28:415-9. (Pubitemid 41169194)
16. Akcakoyun M, Kargin R, Tanalp AC, Pala S, Ozveren O, Akcay M, et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study. Coron Artery Dis. 2008; 19:337-43.
17. Bosevski M, Borozanov V, Tosev S, Georgievska-Ismail L. Is assessment of peripheral endothelial dysfunction useful tool for risk stratifi cation of type 2 diabetic patients with manifested coronary artery disease? Int J Cardiol. 2009; 131:290-2.
18. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of fl ow-mediated dilation to ankle-brachial pressure index. Circulation. 2003;108: 2093-8. (Pubitemid 37337585)
19. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 2003;41:1769-75. (Pubitemid 36584251)
20. Guazzi M, Reina G, Gripari P, Tumminello G, Vicenzi M, Arena R. Prognostic value of fl ow-mediated dilatation following myocardial infarction. Int J Cardiol. 2009;132: 45-50.
21. Hu R, Wang WQ, Lau CP, Tse HF. Gender differences on brachial fl ow-mediated dilation and carotid intima-media thickness for prediction of spontaneous cardiovascular events. Clin Cardiol. 2008;31:525-30.
22. Katz SD, Hryniewicz K, Hriljac I, Balidemaj K, Dimayuga C, Hudaihed A, et al. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation. 2005;111:310-4. (Pubitemid 40165337)
23. Meyer B, Mortl D, Strecker K, Hulsmann M, Kulemann V, Neunteufl T, et al. Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide. J Am Coll Cardiol. 2005; 46:1011-8. (Pubitemid 41316508)
24. Shechter M, Marai I, Marai S, Sherer Y, Sela BA, Feinberg MS, et al. The association of endothelial dysfunction and cardiovascular events in healthy subjects and patients with cardiovascular disease. Isr Med Assoc J. 2007; 9:271-6. (Pubitemid 46692043)
25. Suessenbacher A, Frick M, Alber HF, Barbieri V, Pachinger O, Weidinger F. Association of improvement of brachial artery fl ow-mediated vasodilation with cardiovascular events. Vasc Med. 2006;11:239-44. (Pubitemid 46470502)
26. Takase B, Matsushima Y, Uehata A, Ishihara M, Kurita A. Endothelial dysfunction, carotid artery plaque burden, and conventional exercise-induced myocardial ischemia as predictors of coronary artery disease prognosis. Cardiovasc Ultrasound. 2008;6:61.
27. Wang X, Guo F, Li G, Cao Y, Fu H. Prognostic role of brachial reactivity in patients with ST myocardial infarction after percutaneous coronary intervention. Coron Artery Dis. 2009;20:467-72.
28. Yoshida T, Kawano H, Miyamoto S, Motoyama T, Fukushima H, Hirai N, et al. Prognostic value of fl owmediated dilation of the brachial artery in patients with cardiovascular disease. Intern Med. 2006;45:575-9. (Pubitemid 43880909)
29. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115: 928-35. (Pubitemid 46294733)
30. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassifi cation and beyond. Stat Med. 2008;27:157-72. (Pubitemid 351193639)
31. Herrington DM, Fan L, Drum M, Riley WA, Pusser BE, Crouse JR, et al. Brachial fl ow-mediated vasodilator responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter. J Cardiovasc Risk. 2001;8:319-28. (Pubitemid 33010693)
32. Simova I, Nossikoff A, Denchev S. Interobserver and intraobserver variability of fl ow-mediated vasodilatation of the brachial artery. Echocardiography. 2008;25:77-83.
33. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O, et al. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J. 1995;74:247-53.
34. Welsch MA, Allen JD, Geaghan JP. Stability and reproducibility of brachial artery fl ow-mediated dilation. Med Sci Sports Exerc. 2002;34:960-5. (Pubitemid 34602799)
35. Bots ML, Remme WJ, Luscher TF, Fox KM, Bertrand M, Ferrari R, et al. ACE inhibition and endothelial function: main fi ndings of PERFECT, a sub-study of the EUROPA trial. Cardiovasc Drugs Ther. 2007;21:269-79. (Pubitemid 47387473)
36. De Roos NM, Bots ML, Schouten EG, Katan MB. Within-subject variability of fl ow-mediated vasodilation of the brachial artery in healthy men and women: implications for experimental studies. Ultrasound Med Biol. 2003;29: 401-6. (Pubitemid 36434328)
37. Malik J, Wichterle D, Haas T, Melenovsky V, Simek J, Stulc T. Repeatability of noninvasive surrogates of endothelial function. Am J Cardiol. 2004;94:693-6. (Pubitemid 39165862)
38. Bots ML, Westerink J, Rabelink TJ, de Koning EJ. Assessment of fl ow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J. 2005; 26:363-8. (Pubitemid 40283095)
39. Charakida M, Masi S, Luscher TF, Kastelein JJ, Deanfi eld JE. Assessment of atherosclerosis: the role of fl ow-mediated dilatation. Eur Heart J. 2010;31:2854-61.
40. Plantinga Y, Dogan S, Grobbee DE, Bots ML. Carotid intima-media thickness measurement in cardiovascular screening programmes. Eur J Cardiovasc Prev Rehabil. 2009;16:639-44.